Story perspectives

CDC Recommends Covid Vaccines for Seniors Amid Controversy

9/20/2025

50 4

Summary

Story summary

The CDC's advisory panel recommended Covid vaccinations for individuals 65 and older or those with underlying health conditions, moving away from previous all-age guidance.
This follows FDA approval for the same demographic and raises concerns about vaccine access for younger populations.
The panel faced criticism for fostering vaccine skepticism, with some members making unfounded claims about risks.
Health experts welcomed the lack of new barriers but warned of confusion over vaccination benefits.
Ongoing debates about mRNA vaccine safety persist, despite the CDC's assurance of their safety and non-alteration of DNA.

1 of 1

Story summary

The CDC's advisory panel recommended Covid vaccinations for individuals 65 and older or those with underlying health conditions, moving away from previous all-age guidance.
This follows FDA approval for the same demographic and raises concerns about vaccine access for younger populations.
The panel faced criticism for fostering vaccine skepticism, with some members making unfounded claims about risks.
Health experts welcomed the lack of new barriers but warned of confusion over vaccination benefits.
Ongoing debates about mRNA vaccine safety persist, despite the CDC's assurance of their safety and non-alteration of DNA.